The Actuarial Committee for California’s Workers’ Compensation Insurance Rating Bureau will discuss the impact of pharmaceutical cost reductions on loss development patterns, during a meeting Friday in Oakland.
Pharmaceutical costs are down significantly since 2012, and members of the Actuarial Committee in 2018 recommended a study to determine what effect the decline is having on medical loss development.
In addition to discussing findings from that review, committee members will debate experience rating plan values for the annual regulatory filing, an update on medical severity...
Comments